176 related articles for article (PubMed ID: 7532931)
1. Diabetes mellitus in pancreatic cancer follow-up.
Fogar P; Pasquali C; Basso D; Sperti C; Panozzo MP; Tessari G; D'Angeli F; Del Favero G; Plebani M
Anticancer Res; 1994; 14(6B):2827-30. PubMed ID: 7532931
[TBL] [Abstract][Full Text] [Related]
2. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
Nakamori S; Ishikawa O; Ohigashi H; Sasakuma F; Shimizu T; Nakaizumi A; Furukawa H; Sasaki Y; Imaoka S
Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
[TBL] [Abstract][Full Text] [Related]
3. [Pancreatic carcinoma and diabetes mellitus].
Krechler T; Novotný J; Zeman M; Krska Z; Svestka T; Sváb J; Lukás M; Filipová R; Zák A
Cas Lek Cesk; 2004; 143(2):97-100. PubMed ID: 15077571
[TBL] [Abstract][Full Text] [Related]
4. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis.
Pelaez-Luna M; Takahashi N; Fletcher JG; Chari ST
Am J Gastroenterol; 2007 Oct; 102(10):2157-63. PubMed ID: 17897335
[TBL] [Abstract][Full Text] [Related]
5. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of glucose tolerance function after pancreaticoduodenectomy: comparison between pancreaticogastrostomy and pancreaticojejunostomy.
Ishikawa O; Ohigashi H; Eguchi H; Yokoyama S; Yamada T; Takachi K; Miyashiro I; Murata K; Doki Y; Sasaki Y; Imaoka S
Surgery; 2004 Sep; 136(3):617-23. PubMed ID: 15349110
[TBL] [Abstract][Full Text] [Related]
7. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
[TBL] [Abstract][Full Text] [Related]
8. C-peptide pattern in patients with pancreatic cancer.
Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
10. Impaired glucose metabolism in colorectal cancer.
Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
[TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
12. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
13. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
14. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
15. Preoperative oral glucose tolerance testing in vascular surgery patients: long-term cardiovascular outcome.
van Kuijk JP; Dunkelgrun M; Schreiner F; Flu WJ; Galal W; van Domburg RT; Hoeks SE; van Gestel YR; Bax JJ; Poldermans D
Am Heart J; 2009 May; 157(5):919-25. PubMed ID: 19376322
[TBL] [Abstract][Full Text] [Related]
16. Changes in glucose metabolism after Kausch-Whipple pancreatectomy in pancreatic cancer and chronic pancreatitis patients.
Litwin J; Dobrowolski S; Orłowska-Kunikowska E; Sledziński Z
Pancreas; 2008 Jan; 36(1):26-30. PubMed ID: 18192877
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
[TBL] [Abstract][Full Text] [Related]
18. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
Mula-Abed WA; Al-Naemi AH
Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of oral glucose tolerance test (OGTT) in output patients with advanced chronic renal failure (CRF)].
Rufino M; Barbero P; Hernández D; Torres A; Lorenzo V
Nefrologia; 2007; 27(1):30-7. PubMed ID: 17402877
[TBL] [Abstract][Full Text] [Related]
20. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
Ko GT; Cockram CS; Chan JC
J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
